Schedule 13G ownership disclosure

ANIKA THERAPEUTICS INC

Security class unavailable · CUSIP: 035255108

Event date: 2018-09-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
3.5100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001171843-18-008078
Form type
SC 13G/A
Filer
Anika Therapeutics, Inc.
CIK
CIK 898437
Filed
Nov 20, 2018
Reporting period
Sep 28, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub